Globally, 325 million people live with hepatitis, one of the most neglected diseases. On World Hepatitis Day 2022, the TherVacB project coordinator, Prof. Ulrike Protzer, joins the collective voices from across the world to raise awareness about Hepatitis B (HBV) and empower the HBV community. She contributes to the “The HBV Cure FAQs”, a new collection of short videos answering key questions relating to HBV cure research, by discussing: What do we need to achieve an HBV Cure? Anti-virals, immune therapries, or both?
The HBV Cure FAQs are a new tool aimed at empowering the community by equipping them with the knowledge needed to understand research for a HBV cure that is taking place for their benefit. It is a product of an international consortium of organizations, projects and expert institutions working in and around hepatitis B. The TherVacB project is honoured to be one of the organizations involved along with ICE-HBV, Hepatitis B Foundation, World Hepatitis Alliance, HepBCommunity.org, Australian Centre for Hepatitis Virology, IP-cure-B project, and the Canadian HBV Network.